Recursion Pharmaceuticals, Inc. (RXRX)
3.39
-0.03
(-0.88%)
USD |
NASDAQ |
Mar 16, 16:00
3.38
-0.01
(-0.29%)
After-Hours: 05:26
Recursion Pharmaceuticals Profit Margin (Quarterly) : -304.2% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -416.2% |
| Tango Therapeutics, Inc. | -- |
| Hims & Hers Health, Inc. | 3.33% |
| Novavax, Inc. | 11.91% |
| Geron Corp. | -64.86% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -63.64% |
| Return on Assets | -46.16% |
| Return on Invested Capital | -58.45% |
| Gross Profit Margin (Quarterly) | 24.37% |
| Operating Margin (Quarterly) | -304.8% |
| Return on Net Operating Assets | -93.79% |